CGEM Stock Analysis: Buy, Sell, or Hold?
CGEM - Cullinan Therapeutics, Inc. Common Stock
$11.96
0.04 (0.34%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When CGEM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CGEM shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CGEM shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CGEM is currently trading at $11.96, which is considered extended relative to its 30-day fair value range of $10.15 to $11.80.
Technical Outlook: Technically, CGEM is in a strong uptrend. Immediate support is located at $10.45, while resistance sits at $12.99.
Market Sentiment: CGEM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.43 (+146.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CGEM is in a strong uptrend. Immediate support is located at $10.45, while resistance sits at $12.99.
Market Sentiment: CGEM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.43 (+146.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$10.15 -
$11.80
Company Quality Score
58/100
(HOLD)
Options IV Signal
58th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
64.6%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Options fairly priced (IV 58th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 146.9% below Wall St target ($29.43)
Fair Price Analysis
30-Day Fair Range
$10.15 -
$11.80
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$2.14
(17.9%)
Support & Resistance Levels
Support Level
$10.45
Resistance Level
$12.99
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.59
Wall Street Target
$29.43
(+146.9%)
Last updated: January 31, 2026 9:33 AM ET
Data refreshes hourly during market hours. Next update: 10:33 AM
Data refreshes hourly during market hours. Next update: 10:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGEM showing a specific setup today?
Insider Activity (6 Months)
7
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Lynx1 Capital Management…
BUY
32217 shares
2025-10-17
Lynx1 Capital Management…
BUY
150000 shares
2025-10-16
Lynx1 Capital Management…
BUY
51500 shares
2025-10-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced CGEM Option Strategies
Professional options setups generated by AI based on today's CGEM price and gamma walls.
